Manufacturers of various forms of beta-interferon include Biogen Idec Inc.    From Wordnik.com.  [New Insight Into Multiple-Sclerosis Treatment] Reference

One pathway corresponded to people who respond to beta-interferon, the other to people who don't.    From Wordnik.com.  [New Insight Into Multiple-Sclerosis Treatment] Reference

One pathway corresponded to people who responded to beta-interferon, the other to people who didn't.    From Wordnik.com.  [Multiple-Sclerosis Study Could Help Patients] Reference

But beta-interferon carries flu-like side effects and Tysabri has led to fatal brain disease in rare instances.    From Wordnik.com.  [MS Program Halted Amid Controversy] Reference

Among the MS patients who do respond to beta-interferon, the effectiveness of the drug may potentially be greater than now believed.    From Wordnik.com.  [Multiple-Sclerosis Study Could Help Patients] Reference

Differentiating between responders and nonresponders to beta-interferon could help thousands of people skip the drug and avoid the flu-like symptoms that accompany it, while assuring others that they are likely to benefit, doctors said.    From Wordnik.com.  [New Insight Into Multiple-Sclerosis Treatment] Reference

The researchers, led by Lawrence Steinman and Robert C. Axtell of Stanford's neurology department, concluded that a simple blood test could indicate which patients were most likely to benefit from beta-interferon, which minimizes the relapses suffered by some MS patients.    From Wordnik.com.  [Multiple-Sclerosis Study Could Help Patients] Reference

The researchers, led by Lawrence Steinman and Robert C. Axtell of Stanford's neurology department, concluded that a simple blood test could indicate which patients are most likely to benefit from beta-interferon, which minimizes the relapses suffered by some but not all MS patients.    From Wordnik.com.  [New Insight Into Multiple-Sclerosis Treatment] Reference

In contrast, people given beta-interferon showed signs of progressively worsening disability.    From Wordnik.com.  [Radio New Zealand News Headlines] Reference

In fact, said Steinman, there is some evidence that beta-interferon actually worsened these patients 'conditions.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

Without knowing which samples came from patients who had responded well or poorly to beta-interferon treatment, they went about measuring IL-17 levels in those samples.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

"The other side of the coin is that beta-interferon, if it's given only to those who are predisposed to respond to it, could turn out to be a far better drug than we ever imagined.".    From Wordnik.com.  [THE MEDICAL NEWS] Reference

This was confirmed by brain scans in which alemtuzumab patients showed signs that their brains had actually increased in size, while the beta-interferon patients 'brains shrank over time.    From Wordnik.com.  [British Blogs] Reference

Those with very low detectable blood levels of IL-17F responded well to beta-interferon treatment, experiencing no relapses or instances of required steroids (to quickly shut down a malfunctioning immune system).    From Wordnik.com.  [THE MEDICAL NEWS] Reference

A few years ago while still a PhD student at the University of Alabama, the study's first author, Robert Axtell, had shown that, as in people with multiple sclerosis, beta-interferon can reverse paralysis in mice with EAE.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

The researchers found that beta-interferon improved the condition of animals whose EAE had been induced by gamma-interferon-secreting T cells, but exacerbated symptoms in those whose EAE had been induced by IL-17-secreting T cells.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

Another postdoctoral scholar in the Steinman lab, Brigit deJong, MD, the study's second author, had previously been involved in research in Amsterdam in which multiple-sclerosis patients were treated with beta-interferon and meticulously followed up.    From Wordnik.com.  [THE MEDICAL NEWS] Reference